Rigorous specificity analysis is critical for successful drug development and a safety requirement for monoclonal antibody (mAb) A technology for illuminating proteins on the cell surface promises to boost the success of drug discovery, aid in basic research, Antibody Therapies Targeting Complex Membrane Proteins
Protein Science in Drug Discovery Moderators: Vanita D. Sood, EMD Serono & Christopher Koth, Genentech Speakers: Patrick Webinar - New Ways to Boost Recombinant Protein and Antibody Yields in Transient Systems Spotlight on Antibodies is a podcast from Biointron ( , where we bring you the latest antibody
Breaking barriers in antibody discovery: harnessing divergent Therapeutic lead antibody discovery and solutions
Originally presented at the Antibody Engineering & Therapeutics Digital Week on June 8-10, 2020. Watch this and the other Dispensable loops shield the functionally-important extracellular loops of the essential Gram-negative bacterial outer membrane protein LptD
Transient expression is a fast and reliable way to generate recombinant antibodies and proteins (i.e. products) for all research Accelerating the Antibody Discovery Workflow in the Modern Therapeutic Landscape
Stabilization of native & functional membrane proteins for drug discovery Unlocking Biomarker Discovery with Multiplex Antibody Membrane Arrays 🚀 | Assay Genie De-Risking Antibody Lead Selection: Is your antibody as specific as you think? by Ben Doranz, PhD
DIMA Biotech specializes in expressing and purifying membrane proteins using mammalian cells. Our extensive inventory MPSA-AB5000 is a high-throughput cell-based platform for identifying the targets of antibodies and other ligands that bind to membrane proteins.
Antibody drug development challenges & solutions Complex integral membrane proteins, which are embedded in the cell surface lipid bilayer by multiple transmembrane spanning polypeptides, encompass families PEGS Virtual 2020 Presentation: Integral Molecular has a 95% success rate of discovering high-affinity monoclonal antibodies
Monoclonal antibodies have been an important addition to the biomedical arsenal, but these therapies have limited ability to Dr. Mike Taussig, Cambridge Protein Arrays, and Dr. Fridtjof Lund-Johansen, Oslo University Hospital, look at array and
The discovery and challenges of antibodies targeting GPCRs [GEN Webinars] Towards IND: Specificity Profiling of Antibody-Based Therapies
Speaker: Dr. Nathan Robertson I Group Leader — Antibody Discovery/Protein Engineering I OXGENE Antibody screening using Despite the remarkable growth of antibody-based therapies in recent years, numerous promising targets remain untapped.
Signal transduction across cell membranes plays a central role in human physiology and disease, yet the mechanistic details Webinar: Uni-Select™ Mammalian Cell-Based Membrane Proteins Antibody Screening Applied StemCell provides Custom PRODUCT: Opto Plasma B Discovery 4.0 Product Tour
Looking to streamline your biomarker discovery process? In this video, we dive deep into Assay Genie's Membrane Antibody Isolation of state-dependent monoclonal antibodies against the 12-transmembrane domain SLC2A4 glucose transporter (GLUT4 )
Improve therapeutic monoclonal antibody selection by knowing protein stability using Prometheus Join us for an exclusive session with Dr. Krishna Bhat, Principal Scientist at IONLACE and former researcher at Umeå University Targeting membrane proteins for antibody discovery using phage
Revolutionizing Drug Development: Synthetic Nanodiscs Webinar: AbDrop™: Accelerating Your Antibody Discovery with Single B Solution | 2025 Massive antibody discovery used to probe structure–function
Presented by Carterra and Bio-Techne The COVID-19 pandemic and global effort around vaccine development has heightened This is the fourth episode of our DISCOVER MOLECULAR INTERACTIONS webinar series. Each month we will talk about
This is the second episode of the second season of the DISCOVER MOLECULAR INTERACTIONS webinar series. Each month ChemPartner Webinar: Rapid Discovery of a Diverse Panel of Antibodies Against Membrane Targets
Join us live for our webinar, in collaboration with Drug Target Review. Our Chief Technology Officer, Xavier Leroy and Martine Targeting Transmembrane Proteins: Facilitating Rapid Advancement in Therapeutic Antibody Discovery
Complexities of using membrane proteins as antigens in antibody drug discovery, intrinsic challenges & innovative strategies for success. This presentation, delivered at CAS 2025 and presented by DIMA Biotech, highlights our proprietary platform for the discovery of The current review focuses on the ways in which therapeutic antibody discovery and development technologies are evolving the possibilities for antibody-based
Discovery of Potent anti-PD-L1 Antibodies | High-Throughput Antibody Screening | LSA Platform Immunogens with native conformation and a high-throughput IgG cloning platform are two of the most important key components
Discovery Challenges & Strategies - Targeting Membrane Proteins Antibody discovery in weeks versus years - Isolate, culture, and assay tens of thousands of single cells with the Beacon platform To help Biopharm accelerate its pace on pre-clinical antibody drug lead selection, DIMA Biotech launched an “All Druggable
To exploit highly conserved and difficult drug targets, including multipass membrane proteins, monoclonal antibody discovery efforts increasingly rely on the PEGS Boston Virtual 2020 Presentation: De-Risking Antibody Lead Selection: Is your antibody as specific as you think? by Ben Accelerate COVID19 Antibody Discovery With ProSpeed Single B Cell Technology
Multiple Innovative Technologies & Platforms Empower Antibody Discovery Spotlight on Antibodies | Episode 7 | July 1 - 31, 2025
Antibodies Against Membrane Protein Targets | Discovery on Target Sino Biological is a leading manufacturer of recombinant proteins and antibodies. In addition to our biggest validated recombinant
Webinar "Next Gen P2X4 Antibody Discovery Enabled by the NativeMP+Phage Display Technology " 2025-08-21-DIMA: The Application of Synthetic Nanodisc Technology in Therapeutic Antibody Discovery
DISCOVER pure protein-DNA conjugates: preparation, purification, and analysis with the proFIRE® Antibody Discovery | Integral Molecular
Presented At: LabRoots - Gibco ExpressionWorld 2017 Presented By: Anass Jawhari, PhD - Chief Scientific Officer, CALIXAR This review discusses various membrane protein nanodiscs, and their applications in antibody discovery, alongside current advancements and challenges. Visit the Proteomics Analytics Resource Center: In this webinar, Jeffrey Silva, PhD, Principal
Part 1: Identification of Monoclonal Antibodies that Block Ion Channel Activity Learn how Tetragenetics has developed a strategy Cracking Protein Structures: From Cryo-EM to Antibody Discovery – A Webinar with Dr. Krishna Bhat
The 13th Annual Antibodies Against Membrane Protein Targets brings together leading researchers and industry innovators to tackle the unique challenges and DISCOVER complex membrane targets: measure binding to GPCRs, ion channels and more directly on cells
Generating protein reagents to evaluate the antibody and CD8+ T cell responses to SARS-CoV-2 Latest Developments in High Titer Transient Protein Expression using the ExpiCHO Overview of the CRO Service Platforms for Recombinant Protein Expression and Antibody Development
Presented At: LabRoots - Gibco ExpressionWorld 2017 Presented By: Jon Zmuda, PhD - Director, Cell Biology, Life Sciences Protein Science in Drug Discovery
Antibody discovery at the edge of impossible Integral Molecular has a 95% success rate of discovering high-affinity monoclonal antibodies against multipass membrane Are you working on antibody drug development with a challenging target, such as membrane proteins (e.g. GPCRs and ion
High Throughput Characterization of Ion Channel Activity Blocking mAbs with Array SPR | LSA Platform Therapeutic mAb Discovery for Multi-Pass Transmembrane Protein Targets | DIMA Biotech @ CAS 2025
The successful isolation of antibodies from a naive scFv library is described for three membrane bound proteins; human CD83, canine CD117 and bat CD11b. Presented By: Natalia Guadalupe Herrera Speaker Biography: My name is Natalia Guadalupe Herrera and I obtained a BS in
Webinar: AbDrop™ Speeds: Accelerating Your Antibody Discovery with Single B Solution Speaker: Gang Liu, Ph.D., Associate Webinar: Conquering Undruggable Targets to Obtain Preclinical Antibodies In this webinar, Dr. Marayna Löwe and Dr. Mathieu Schaff will provide valuable knowledge and practical insights into copolymers
David MacMillan: A “flashlight” to identify cellular proteins for drug discovery Abstract Transmembrane proteins usually play pivotal roles in various cellular processes, including signal transduction, cell Off-target binding remains a major challenge in antibody development, often leading to safety concerns and failed programs.
Lessons in Generating Monoclonal Antibodies against Multipass Membrane Proteins- Ross Chambers, PhD The development of antibody drugs has greatly depended on the establishment of new technologies and platforms, which are
Using Single B Technology to Develop Lead Antibody Molecules on GPCR Targets In this webinar, we introduce single cell technology in immunology and antibody screening, including its emergence, various Using AI and Synthetic Biology to Go Where Antibody Therapies Can’t
Review: Membrane protein nanodiscs for antibody discovery Everyday researchers face the daunting challenge of creating more effective biotherapeutics. Many candidates fail due to a lack of Speakers: Andrew Hunt, Phd Student, Northwestern University Alex Pierson, Technical Product Manager for the Access Solutions
The MPS Discovery Engine® enables the isolation of monoclonal antibodies targeting complex membrane proteins. Click here to learn more. Discovery On Target 2020: Isolation of state-dependent monoclonal antibodies against GLUT4
Discovery of Therapeutic Antibodies Targeting Complex Multi Webinar: Best Practices for Antibody Specificity Testing for IND Submissions TARGATT A Mammalian Cell Library System for Antibody Protein Screening
Comprehensive Specificity Profiling of Antibody-Based Therapeutics Using the Membrane Proteome Array This webinar assembles experts in antibody discovery and development and features presentations from Integral Molecular, Take a tour of our latest antibody discovery workflow, Opto Plasma B Discovery 4.0.
Presented By: Dr. Donghui Ma Speaker Biography: Dr. Donghui Ma, an accomplished biotechnology pioneer, serves as the Antibody Validation 08: Protein arrays and mass spectrometry Accelerating Antibody Discovery with Cell Free Protein Synthesis and Automation
The human animal is multicellular – an organism comprised of trillions of smaller organisms. As with any complex organisation, Integrated antibody discovery solution for multi-pass transmembrane target Presented By: François Romagné Speaker Biography: Professor of immunotechnology at Aix-Marseille University (AMU),
Improving Drug Discovery: A Molecular Understanding of Cell Receptors (Short) Scientist Stories: Andrew Kruse, GPCRs & Antibody Discovery Dr Sachdev Sidhu
Membrane Protein Antibody Discovery, MPS AB5000 | Kyinno Bio De Novo Design of Epitope-Specific Antibodies for Membrane Proteins with High Specificity & Function Targeting Proteomics to Decipher Biology for the Drug Development Pipeline
Advancements in AI are revolutionizing antibody design, enabling the creation of epitope-specific antibodies with exceptional 6 Steps to Success in Discovering Monoclonal Antibodies Against Multipass Membrane Proteins
COVID-19 mutant variants | Biology Solutions | High-Throughput Antibody Screening | LSA Platform